2020-000543-31
An Adaptive Phase 2, Open-Label, Multicentre Study Investigating the Pharmacokinetics, Pharmacodynamics, Efficacy and Safety of Teverelix Trifluoroacetate, a Gonadotropin-releasing Hormone (GnRH) A...
Antev Ltd.·EU Clinical Trials Register
Study focus
- Disease/Condition
- Prostate cancer
Sponsor & location
- Primary sponsor
- Antev Ltd.
Timeline & enrollment
- Phase
- N/A
- Start date
- N/A
- End date
- N/A
ICD-10 classifications
Malignant neoplasm of prostateHyperplasia of prostateDisorder of prostate, unspecifiedOther disorders of prostateCarcinoma in situ: Prostate
Data source
- Registry
- EU Clinical Trials Register
- Trial ID
- 2020-000543-31
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for 2020-000543-31 through Pure Global AI's free database. This phase not specified trial is sponsored by Antev Ltd. and is currently status unknown. The study focuses on Prostate cancer.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.